Jing Qian co-founded the Center for China Analysis (CCA) at the Asia Society Policy Institute alongside the Hon. Dr. Kevin Rudd, to whom he served as a Senior Advisor for almost a decade. As the Managing Director of CCA, Jing leads its strategy, research, and policy work on China, which includes coordination of a series of Track 1.5/2 dialogues. Jing also co-leads the Decoding Chinese Politics and Cure4Cancer International Clinical Trials Collaboration projects.

Qian serves as an Advisory Board Member of the Bloomberg New Economy Forum and is a founding member of both the Bloomberg New Economy International Cancer Coalition and the AstraZeneca Global Health Equity Advisory Board. Qian is also a Senior Fellow at the Munk School of Global Affairs and Public Policy at the University of Toronto.

Qian’s own research is focused on China's elite politics and its impact on China's domestic and foreign policy, particularly regarding U.S.-China relations. His analyses have appeared in Bloomberg, CBC, The Economist, New York Times, Wall Street Journal, Harvard Business Review, Nature, Nature Medicine, etc.

A graduate of Harvard, Qian is deeply interested in the liberal arts. He co-founded Project Agora, with H.E. George Papandreou, aiming to educate the citizens and citizen-leaders for our society through the transformative power of a liberal arts education.

Last Updated: January 13, 2025

Viewpoint

01.16.25

U.S. and China Just Set New Road Rules for Science Collaboration. Americans Will Benefit If We Don't Scrap Joint Research

Brendan Kelly & Jing Qian from Foreign Policy
Amid heightened U.S.-China strategic and technology competition, bilateral scientific collaboration has become increasingly challenging. China’s broad military-civil fusion and espionage efforts have heightened Washington’s concerns that any...